» Articles » PMID: 17347686

Evidence for Tissue-resident Mesenchymal Stem Cells in Human Adult Lung from Studies of Transplanted Allografts

Abstract

The origin and turnover of connective tissue cells in adult human organs, including the lung, are not well understood. Here, studies of cells derived from human lung allografts demonstrate the presence of a multipotent mesenchymal cell population, which is locally resident in the human adult lung and has extended life span in vivo. Examination of plastic-adherent cell populations in bronchoalveolar lavage samples obtained from 76 human lung transplant recipients revealed clonal proliferation of fibroblast-like cells in 62% (106 of 172) of samples. Immunophenotyping of these isolated cells demonstrated expression of vimentin and prolyl-4-hydroxylase, indicating a mesenchymal phenotype. Multiparametric flow cytometric analyses revealed expression of cell-surface proteins, CD73, CD90, and CD105, commonly found on mesenchymal stem cells (MSCs). Hematopoietic lineage markers CD14, CD34, and CD45 were absent. Multipotency of these cells was demonstrated by their capacity to differentiate into adipocytes, chondrocytes, and osteocytes. Cytogenetic analysis of cells from 7 sex-mismatched lung transplant recipients harvested up to 11 years after transplant revealed that 97.2% +/- 2.1% expressed the sex genotype of the donor. The presence of MSCs of donor sex identity in lung allografts even years after transplantation provides what we believe to be the first evidence for connective tissue cell progenitors that reside locally within a postnatal, nonhematopoietic organ.

Citing Articles

MNK-driven eIF4E phosphorylation regulates the fibrogenic transformation of mesenchymal cells and chronic lung allograft dysfunction.

Walker N, Ibuki Y, McLinden A, Misumi K, Mitchell D, Kleer G J Clin Invest. 2024; 134(16).

PMID: 39145446 PMC: 11324311. DOI: 10.1172/JCI168393.


Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer.

Mori J, Elhussin I, Brennen W, Graham M, Lotan T, Yates C Nat Rev Urol. 2023; 21(5):258-273.

PMID: 37907729 PMC: 11058122. DOI: 10.1038/s41585-023-00827-x.


Lung mesenchymal cells from patients with COVID-19 driven lung fibrosis: Several features with CTD-ILD derived cells but with higher response to fibrogenic signals and might be more pro-inflammatory.

Bozzini S, Della Zoppa M, Bagnera C, Bozza E, Croce S, Valsecchi C Biomed Pharmacother. 2023; 162:114640.

PMID: 37004325 PMC: 10063673. DOI: 10.1016/j.biopha.2023.114640.


Regenerative medicine in lung diseases: A systematic review.

Adamic N, Vengust M Front Vet Sci. 2023; 10:1115708.

PMID: 36733636 PMC: 9887049. DOI: 10.3389/fvets.2023.1115708.


Novel approaches for long-term lung transplant survival.

Miller C, O J, Allan J, Madsen J Front Immunol. 2022; 13:931251.

PMID: 35967365 PMC: 9363671. DOI: 10.3389/fimmu.2022.931251.


References
1.
Ortiz L, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N . Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A. 2003; 100(14):8407-11. PMC: 166242. DOI: 10.1073/pnas.1432929100. View

2.
Noth U, Osyczka A, Tuli R, Hickok N, Danielson K, Tuan R . Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res. 2002; 20(5):1060-9. DOI: 10.1016/S0736-0266(02)00018-9. View

3.
Korbling M, Estrov Z . Adult stem cells for tissue repair - a new therapeutic concept?. N Engl J Med. 2003; 349(6):570-82. DOI: 10.1056/NEJMra022361. View

4.
Hashimoto N, Jin H, Liu T, Chensue S, Phan S . Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest. 2004; 113(2):243-52. PMC: 310750. DOI: 10.1172/JCI18847. View

5.
Short B, Brouard N, Occhiodoro-Scott T, Ramakrishnan A, Simmons P . Mesenchymal stem cells. Arch Med Res. 2004; 34(6):565-71. DOI: 10.1016/j.arcmed.2003.09.007. View